Ionizing radiation and genetic risks IX. Estimates of the frequencies of mendelian diseases and spontaneous mutation rates in human populations: A 1998 perspective

Mutation Research - Reviews in Mutation Research

Volumn 411, Issue 2, 1998, Pages 129-178

  Sankaranarayanan, K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genetic risk; Human spontaneous rate; Ionizing radiation; Mendelian disease

Indexed keywords

FEMALE; GENETIC DISORDER; GENETIC RISK; HUMAN; IONIZING RADIATION; MALE; MUTATION RATE; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0031671781     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(98)00012-X     Document Type: Article

References (286)

1. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, The 1993 Report to the General Assembly with Scientific Annexes, United Nations, New York, 1993.
2. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, The 1977 Report to the General Assembly with Scientific Annexes, United Nations, New York, 1977.
3. NAS, The BEIR V Report, Health Effects of Exposure to Low Levels of Ionizing Radiation, National Academy of Sciences-National Research Council, Washington, DC, 1990.
4. J.V. Neel, S.E. Lewis, The comparative radiation genetics of humans and mice, Annu. Rev. Genet. 24 (1990) 327-362.
5. R. Chakraborty, N. Yasuda, K. Sankaranarayanan, Ionizing radiation and genetic risks: VII. The concept of mutation component and its use in risk estimation for Mendelian diseases, Mutat. Res., 1998, in press.
6. C. Denniston, R. Chakraborty, K. Sankaranarayanan, Ionizing radiation and genetic risks: VIII. The concept of mutation component and its use in risk estimation for multifactorial diseases, Mutat. Res., 1998, in press.
7. A.C. Stevenson, The load of hereditary defects in human population, Radiat. Res. Suppl. 1 (1959) 306-325.
8. B.K. Trimble, J.H. Doughty, The amount of hereditary disease in human populations, Ann. Hum. Genet. 38 (1974) 199-223.
9. C.O. Carter, Monogenic disorders, J. Med. Genet. 14 (1977) 316-320.
10. C.O. Carter, Contribution of gene mutations to genetic disease in humans, in: K.C. Bora, G.R. Douglas, E.R. Nestmann (Eds.), Progress in Mutation Research, Vol. 3, Elsevier, Amsterdam, 1982, pp. 1-8.
11. C. Denniston, Low level radiation and genetic risk estimation in man, Annu. Rev. Genet. 16 (1982) 329-355.
12. P.A. Baird, T.W. Anderson, H.B. Newcombe, H.B. Lowry, Genetic disorders in children and young adults: a population study, Am. J. Hum. Genet. 42 (1988) 677-693.
13. K. Sankaranarayanan, Invited review: prevalence of genetic and partially genetic diseases in man and the estimation of genetic risks of exposure to ionizing radiation, Am. J. Hum. Genet. 42 (1988) 651-662.
14. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, The 1988 Report to the General Assembly with Annexes, United Nations, New York, 1988.
15. A. Czeizel, K. Sankaranarayanan, The load of genetic and partially genetic diseases in man: I. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life, Mutat. Res. 128 (1984) 73-103.
16. A. Czeizel, K. Sankaranarayanan, A. Losonci et al., The load of genetic and partially genetic diseases in man: II. Some selected common multifactorial diseases: estimates of detriment in terms of years of lost and impaired life, Mutat. Res. 196 (1988) 259-292.
17. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, Ionizing radiation: sources and biological effects, The 1982 Report to the General Assembly with Annexes, United Nations, New York, 1982.
18. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation, The 1986 Report to the General Assembly with Annexes, United Nations, New York, 1986.
19. NAS, The effects on populations of exposure to low levels of ionizing radiation, The BEIR III Report, National Academy of Sciences, National Research Council, Washington, DC, 1980.
20. M.J. Khoury, T.H. Beatty, B.N. Cohen, Fundamentals of Genetic Epidemiology, Oxford Univ. Press, New York, 1993.
21. McKusick, V.M., OMIM On Line Mendelian Inheritance In Man, http://www.ncbi.nlm.nih.gov/omim, January 1998.
22. T.L. Innerarity, R.W. Mahley, K.H. Weisgraber et al., Familial defective apolipoprotein B-100: a mutation that causes hypercholesterolemia, J. Lipid Res. 31 (1990) 1337-1349.
23. J.L. Goldstein, M.S. Brown, The low density lipoprotein pathway and its relation to atherosclerosis, Annu. Rev. Biochem. 46 (1977) 897-930.
24. A.S. Whittemore, G. Gong, J. Itnyre, Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer, Am. J. Hum. Genet. 60 (1997) 496-504.
25. T.H. Bothwell, R.W. Charlton, A.G. Motulsky, Hemochromatosis, in: C.R. Scriver et al. (Eds.), The Molecular Basis of Inherited disease, McGraw-Hill, New York, 1995, pp. 2237-2269.
26. C. Niederau, R. Fisher, A. Purschel et al., Long term survival in patients with hereditary hemochromatosis, Gasteroenterology 110 (1995) 1107-1119.
27. C.Q. Edwards, L.M. Griffen, D. Goldgar et al., Prevalence of hemochromatosis among 11,065 presumably healthy blood donors, New Engl. J. Med. 318 (1988) 1355-1362.
28. B.A. Leggett, J.W. Halliday, N.N. Brown et al., Prevalence of hemochromatosis amongst asymptomatic Australians, Br. J. Haematol. 74 (1990) 525-530.
29. P. Wiggers, J. Dalhoj, H. Kiaer et al., Screening for hemochromatosis: prevalence among Danish blood donors, J. Intern. Med. 230 (1991) 265-270.
30. J.N. Feder, A. Gnirke, W. Thomas et al., A novel MHC-class 1-like gene is mutated in patients with hereditary hemochromatosis, Nat. Genet. 13 (1996) 399-409.
31. A.V. Flannery, M.C. Hirst, S.J.L. Knight et al., The fragile-X syndrome, Biochim. Biophys. Acta 1271 (1995) 293-303.
32. S. Miwa, H. Fujii, Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes, Am. J. Hematol. 51 (1996) 122-132.
33. E. Beutler, G6PD deficiency, Blood 84 (1994) 3613-3636.
34. U. Testa, T. Meloni, A. Lania et al., Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Sardinia, Hum. Genet. 56 (1980) 99-105.
35. D.T.Y. Chiu, L. Zuo, L. Chao et al., Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in patients of Chinese descent and identification of new base substitutions in the human G6PD gene, Blood 81 (1993) 2150-2154.
36. L. Luzzatto, G. Battistuzzi, Glucose-6-phosphate dehydrogenase, Adv. Hum. Gen. 14 (1985) 217-329.
37. T. Cohen, Genetic markers in migrants to Israel, Isr. J. Med. Sci. 7 (1971) 1509-1514.
38. L. Luzzatto, A. Mehta, Glucose-6-phosphate dehydrogenase deficiency, in: C.R. Scriver et al. (Eds.), The Metabolic Basis of Inherited Disease, 7th edn., McGraw-Hill, New York, 1995, pp. 3367-3398.
39. Genome Database, GDB Online: http://www.gdb.org., January 1998.
40. B. Lewin, Genes IV, Oxford Univ. Press. Oxford, 1990.
41. S.H. Cross, A.P. Bird, CpG islands and genes, Curr. Opin. Genet. Dev. 5 (1995) 309-314.
42. R.M. Goodman, A.G. Motulsky (Eds.), Genetic Diseases Among Ashkenazi Jews, Raven Press, New York, 1979.
43. B. Roa, A. Boyd, K. Volcik, C. Richards, Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2, Nat. Genet. 14 (1996) 185-187.
44. P. Tonin, B. Weber, K. Offit et al., Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families, Nat. Med. 2 (1996) 1179-1183.
45. E. Levy-Lahad, R. Catane, S. Eisenburg et al., Recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and breast-ovarian cancer families, Am. J. Hum. Genet. 60 (1997) 1059-1067.
46. C.I. Szabo, M.C. King, Population genetics of BRCA1 and BRCA2, Am. J. Hum. Genet. 60 (1997) 1013-1020.
47. N. Risch, D. De Leon, L. Ozelius et al., Genetic analysis of torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population, Nat. Genet. 9 (1995) 152-159.
48. N.A. Ellis, J. German, Molecular genetics of Bloom's syndrome, Hum. Mol. Genet. 5 (1996) 1457-1463, Review.
49. A.G. Motulsky, Jewish diseases and origins, Nat. Genet. 9 (1995) 99-101.
50. F. Vogel, A.G. Motulsky, Human Genetics: Problems and Approaches, Springer, Berlin, 1997.
51. A. De la Chapelle, Disease gene mapping in isolated human populations: the example of Finland, J. Med. Genet. 30 (1993) 857-865.
52. L. Peltonen, P. Pekkarinen, J. Aaltonen, Messages from an isolate: lessons from the Finnish gene pool, Biol. Chem. Hoppe-Seyler 376 (1995) 697-704.
53. A. Petrii-Bosch, T. Peelen, M. Van Vliet et al., BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients, Nat. Genet. 17 (1997) 341-345.
54. S. Thorlacius, S. Sigurdsson, H. Bjarnadottir et al., Study of a single BRCA2 mutation with high carrier frequency in a small population, Am. J. Hum. Genet. 60 (1997) 1079-1084.
55. A.S. Teebi, Autosomal recessive diseases among Arabs: an overview from Kuwait, J. Med. Genet. 31 (1994) 224-233.
56. A.S. Teebi, T.I. Farag, Genetic Disorders among Arab Populations, Oxford Monographs on Medical Genetics, No. 30, Oxford Univ. Press, Oxford, 1997.
57. Genetic Services in Europe: A Comparative Study of 31 Countries by the Concerted Action on Genetic Services in Europe, European Journal of Human Genetics 5 (Suppl 2) (1997) 1-220.
58. NAS, The Effects on Populations of Exposure to Low Levels of Ionizing Radiation, The BEIR Report, National Academy of Sciences, National Research Council, Washington, DC, 1972.
59. N.E. Morton, Mutation rates for human autosomal recessives, in: E.B. Hook, I.H. Porter (Eds.), Population and Biological Aspects of Human Mutation, Academic Press, New York, 1981, pp. 361-375.
60. J.F. Crow, C. Denniston, Mutations in human populations, Adv. Hum. Genet. 14 (1985) 59-123.
61. J.F. Crow, M. Kimura. An Introduction to Population Genetic Theory. Harper & Row, New York, 1970.
62. F. Vogel, R. Rathenburg, Spontaneous mutations in man, Adv. Hum. Genet. 5 (1975) 223-318.
63. J.D. Childs, The effect of a change of mutation rate on the incidence of dominant and X-linked recessive disorders in man, Mutat. Res. 83 (1981) 145-158.
64. F.W. Crowe, W.J. Schull, J.V. Neel, A Clinical, Pathological and Genetic Study of multiple neurofibromatosis, C.C. Thomas Publishing, Springfield, IL, 1956.
65. A.C. Stevenson, C.B. Kerr, On the distribution of frequencies of mutation to genes determining harmful traits in man, Mutat. Res. 4 (1967) 339-352.
66. L.L. Cavalli-Sforza and W.F. Bodmer, The Genetics of Human Populations, Freeman, San Francisco, CA, 1971.
67. M. Koenig, E.P. Hoffman, C.J. Bertelson et al., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell 50 (1987) 509-517.
68. R.G. Roberts, A.J. Coffey, M. Bobrow, D.R. Bentley, Exon structure of the human dystrophin gene, Genomics 16 (1993) 536-538.
69. S.E. Antonarakis, The molecular genetics of hemophilia A and B in man, Adv. Hum. Genet. 17 (1988) 27-59.
70. E.E. Eichler, S. Richards, R.A. Gibbs, D.L. Nelson, Fine structure of the human FMR1 gene, Hum. Mol. Genet. 2 (1993) 1147-1153.
71. D.N. Cooper, M. Krawczak, Human Gene Mutation, BIOS Sci. Publ., Oxford, 1993.
72. G.A. Bellus, T.W. Hefferson, I. Rosa et al., Achondroplasia is defined by recurrent mutations of FGFR3, Am. J. Hum. Genet. 56 (1995) 368-373.
73. M. Muenke, U. Schell, Fibroblast growth factor receptor mutations in human skeletal disorders, Trends Genet. 11 (1995) 308-313.
74. J.J. Mulvihill, Craniofacial syndromes: no such thing as a single gene disease, Nat. Genet. 9 (1995) 101-103.
75. J.F. Crow, How much do we know about spontaneous human mutation rates?, Environ. Mol. Mutagen. 21 (1993) 122-129.
76. J.F. Crow, The high spontaneous mutation rate: is it a health risk?, Proc. Natl. Acad. Sci. USA 94 (1997) 8380-8386.
77. N. Risch, E.W. Reich, W.W. Wishnick, J.G. McCarthy, Spontaneous mutation and paternal age in humans, Am. J. Hum. Genet. 41 (1987) 218-248.
78. K.M. Carlson, J. Bracamontes, C.E. Jackson et al., Parent of origin effects in multiple endocrine neoplasia type 2B, Am. J. Hum. Genet. 55 (1994) 1076-1082.
79. I. Schuffenecker, N. Ginet, D. Goldgar et al., Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma, Am. J. Hum. Genet. 60 (1997) 233-237.
80. Moloney, S.F. Slaney, M. Oldridge et al., Exclusive paternal origin of new mutations in Apert syndrome, Nat. Genet. 13 (1996) 48-53.
81. J.B. Drost, W.R. Lee, Biological basis of germline mutation: comparisons of spontaneous germline mutation rates among Drosophila, mouse and human, Environ. Mol. Mutagen. 25 (1995) 48-64, Suppl. 26.
82. S.S. Sommer, R.P. Ketterling, The factor IX gene as a model for analysis of human germline mutations: an update, Hum. Mol. Genet. 5 (1996) 1505-1514, Review.
83. B.H.J. Chang, L.C. Shimmin, S-K. Shyue, D. Hewett-Emmett, Weak male-driven evolution in rodents, Proc. Natl. Acad. Sci. USA 91 (1995) 827-831.
84. W.-H. Li, D.L. Ellsworth, J. Krushkal, Rates of nucleotide substitutions in primates and rodents and the generation-time effect hypothesis, Mol. Phylogenet. Evol. 5 (1996) 182-187.
85. L.B. Russell, Analysis of the albino-locus region of the mouse: II. Mosaic mutants, Genetics 91 (1979) 141-147.
86. L.B. Russell, W.L. Russell, Spontaneous mutations recovered as mosaics in the mouse specific locus test, Proc. Natl. Acad. Sci. USA 93 (1996) 13072-13077.
87. A. Schalet, A study of spontaneous visible mutations in Drosophila melanogaster, PhD Thesis, Indiana University, Bloomington, IN, 1960, 90 pp.
88. A. Schalet, The distribution and complementation relationships between spontaneous X- linked recessive lethal mutations recovered from crossing long-term laboratory stocks of Drosophila melanogaster, Mutat. Res. 163 (1986) 115-144.
89. J. Favor, A. Neuhauser-Klaus, Genetic mosaicism in the house mouse, Annu. Rev. Genet. 28 (1994) 27-47.
90. R.C. Woodruff, H. Huai, J.N. Thompson, Clusters of identical mutations in the evolutionary landscape, Genetica 98 (1996) 149-160.
91. J.G. Hall, Review and hypotheses: somatic mosaicism: observations related to clinical genetics, Am. J. Hum. Genet. 43 (1988) 355-363.
92. J.H. Edwards, Familiarity, recessivity and germline mosaicism, Ann. Hum. Genet. 53 (1989) 33-47.
93. E. Bakker, H. Venema, J.T. Den Dunnen et al., Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations, J. Med. Genet. 26 (1989) 553-559.
94. T. Grimm, B. Mueller, C.R. Mueller, M. Janka, Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy, J. Med. Genet. 27 (1990) 683-687.
95. L.B. Russell, W.L. Russell, Correction to the article which appeared in: Proc. Natl. Acad. Sci. USA 93 (1996) 13072-13077 (Ref. 86), Proc. Natl. Acad. Sci. USA 94 (1997) 4233.
96. L.B. Russell, W.L. Russell, Correction to the article which appeared in: Proc. Natl. Acad. Sci. USA 93 (1996) 13072-13077 (Ref. 86), Proc. Natl. Acad. Sci. USA 94 (1997) 4233.
97. P.B. Selby, Discovery of numerous clusters of spontaneous mutations in the specific-locus test in mice necessitates major increases in estimates of doubling doses, Genetica, 1998, in press.
98. P.B. Selby, Major impact of gonadal mosaicism on hereditary risk estimation, origin of hereditary diseases and evolution, Genetica, 1998, in press.
99. K. Sankaranarayanan, Ionizing radiation, genetic risk estimation and molecular biology: impact and inferences, Trends Genet. 9 (1993) 79-84.
100. K. Sankaranarayanan. Re-evaluation of genetic radiation risks, in: U. Hagen et al. (Eds.), Radiation Research 1895-1995, Proc. X, Int. Congress Radiat. Res., Vol 2, Universitäts-druckerei H. Stürtz, Würzburg, Germany, 1995, pp. 1138-1142.
101. K. Sankaranarayanan, Environmental chemical mutagens and genetic risks: lessons from radiation genetics, Environ. Mol. Mutagen. 28 (1996) 65-70.
102. P.C. Harris, C.J. Ward, B. Peral, J. Hughes, Autosomal dominant polycystic kidney disease: molecular analysis, Hum. Mol. Genet. 4 (1995) 1745-1749, Review.
103. H.C. Dietz, R.E. Pyeritz, Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders, Hum. Mol. Genet. 4 (1995) 1799-1809, Review.
104. A. Tybjaerg-Hansen, S.E. Humphries, Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary heart disease, Atherosclerosis 96 (1992) 91-107.
105. C.R. Pullinger, L.K. Hennessy, J.A. Love et al, Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity (abstract), Circulation 88 (1993) 1-322.
106. N.B. Myant, Familial defective apolipoprotein B-100: a review including some comparisons with familial hypercholesterolemia, Atherosclerosis 104 (1993) 1-18.
107. A.R. Miserez, R. Laager, N. Chiodetti, U. Keller, High prevalence of familial defective apolipoprotein B-100 in Switzerland, J. Lipid Res. 35 (1994) 574-583.
108. E.B. Claus, N.J. Risch, W.D. Thompson, Age at onset as an indicator of familial risk of breast cancer, Am. J. Epidemiol. 131 (1990) 961-972.
109. E.B. Claus, N.J. Risch, W.D. Thompson, Genetic analysis of breast cancer in the cancer and steroid hormone study, Am. J. Hum. Genet. 48 (1991) 232-242.
110. M.C. King, Breast cancer genes: how many, where and who are they?, Nat. Genet. 2 (1992) 89-90.
111. J.M. Hall, M.K. Lee, B. Newman et al., Linkage of early-onset familial breast cancer to chromosome 17q21, Science 250 (1990) 1684-1689.
112. Y. Miki, J. Swenson, D. Shattuck-Eidens et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science 266 (1994) 66-71.
113. R. Wooster, G. Bignell, J. Lancaster et al., Identification of the breast cancer susceptibility gene BRCA2, Nature 378 (1995) 789-792.
114. S.V. Tavtigian, J. Simard, J. Rommens et al, The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds, Nat. Genet. 12 (1996) 333-337.
115. B. Newman, H. Mu, L.M. Butler et al., Frequency of breast cancer attributable to BRCA1 in a population-based series of American women, JAMA 279 (1998) 915-921.
116. K.E. Malone, J.R. Daling, J.D. Thompson et al, BRCA1 mutations and breast cancer in the general population, JAMA 279 (1998) 922-929.
117. D. Ford, D.F. Easton, J. Peto, Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer, Am. J. Hum. Genet. 57 (1995) 1457-1462.
118. P.S. Harper, The epidemiology of Huntington's disease, Hum. Genet. 89 (1992) 365-376.
119. P.J. Morrison, W.P. Johnston, N.C. Nevin, The epidemiology of Huntington's disease in Northern Ireland, J. Med. Genet. 32 (1995) 524-530.
120. V.M. Riccardi, Von Recklinghausen neurofibromatosis, New Engl. J. Med. 305 (1981) 1617-1627.
121. M. Little, N.E. Morton, Segregation analysis of peripheral neurofibromatosis (NFl), J. Med. Genet. 27 (1990) 307-310.
122. D.G.R. Evans, S.M. Huson, D. Donnai et al., A genetic study of type 2 neurofibromatosis in the United Kingdom: 1. Prevalence, mutation rate and confirmation of maternal transmission effect on severity, J. Med. Genet. 29 (1982) 841-846.
123. A. Hunt, R.H. Lindenbaum, Tuberous sclerosis: a new estimate of prevalence within the Oxford region, J. Med. Genet. 1 (1984) 272-277.
124. J.P. Osborne, A. Fryer, D. Webb, Epidemiology of tuberous sclerosis, Ann. New York Acad. Sci. 615 (1991) 125-127.
125. K. Hirayama, T. Takayanagi, R. Nakamura et al, Spinocerebellar degeneration in Japan: a nationwide epidemiological and clinical study, Acta Neurol. Scand. 89 (1994) 1-22, Suppl. 153.
126. K. Ishikawa, H. Tanaka, M. Saito et al., Japanese families with autosomal dominant pure cerebellar ataxia map to chromosome 19p13.1-p13.2 and are strongly associated with mild CAG expansions in the spinocerebellar ataxia type 6 gene in chromosome 19p13.1, Am. J. Hum. Genet. 61 (1997) 336-346.
127. G. Inazaki, K. Kumagai, H. Naito, Dentatorubral pallidoluysian atrophy (DRPLA): its distribution in Japan and prevalence rate in Niigata, Seishin-Igaku 32 (1990) 1135-1138, Cited in Ref. 127.
128. O. Onodera, M. Oyake, H. Tano et al., Molecular cloning of a full length cDNA for dentatorubral pallidoluysian atrophy and regional expressions of the expanded alleles in the central nervous system, Am. J. Hum. Genet. 57 (1995) 1050-1060.
129. P.S. Harper, Myotonic Dystrophy, 2nd edn., Saunders, London, 1989.
130. C.L. Winchester, K.J. Johnson, How a dynamic mutation manifests in myotonic dystrophy, in: S.E. Humphries, S. Malcolm (Eds.), From Genotype to Phenotype, Chap. 8, BIOS Sci. Publ., Oxford, 1994.
131. F. Skre, Genetic and clinical aspects of Charcot-Marie-Tooth disease, Clin. Genet. 6 (1974) 98-118.
132. P.I. Patel, J.R. Lupski, Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease, Trends Genet. 10 (1994) 128-133.
133. J.M. Polo, J. Calleja, O. Cambarros et al., Hereditary ataxias and paraplegias in Canabria, Spain., Brain 114 (1991) 855-866.
134. E. Reid, Pure hereditary spastic paraplegia, J. Med. Genet. 34 (1997) 499-503.
135. P.W. Lunt, P.S. Harper, Genetic counselling in facioscapulohumeral muscular dystrophy, J. Med. Genet. 28 (1991) 655-664.
136. R.C. Hennekam, Hereditary multiple exotoses, J. Med. Genet. 28 (1991) 262-266.
137. G.A. Schmale, E.U. Conrad, W.H. Rashkind, The natural history of hereditary multiple exotoses, J. Bone Jt. Surg. 76 (1994) 986-992.
138. D. Stickens, G. Clines, D. Burbee et al., The EXT multiple exotoses gene defines a family of putative tumour suppressor genes, Nat. Genet. 14 (1996) 25-32.
139. W. Wuyts, W. van Hul, J. Wauters et al., Positional cloning of a gene involved in hereditary multiple exotoses, Hum. Mol. Genet. 5 (1996) 1547-1557.
140. C.L. Wickland, R.M. Pauli, D. Johnston, J.T. Hecht, Natural history study of hereditary multiple exotoses, Am. J. Med. Genet. 55 (1995) 43-46.
141. I.M. Orioli, E.E. Castilla, J.G. Barboso-Neto, The birth prevalence rates for skeletal dysplasias, J. Med. Genet. 23 (1986) 328-332.
142. P.E. Anderson, M. Hauge, Congenital generalized bone dysplasias: a clinical, radiological and epidemiological study, J. Med. Genet. 26 (1989) 37-44.
143. C. Stoll, B. Dott, M.P. Roth, Y. Alembik, Birth prevalence of skeletal dysplasias, Clin. Genet. 35 (1989) 88-92.
144. M.L. Martinez-Frias, A. Cereijo, E. Bermeijo et al., Epidemiological aspects of mendelian syndromes in a Spanish population sample, Am. J. Med. Genet. 38 (1991) 622-625.
145. P.H. Byers, Osteogenesis imperfecta, in: P.M. Royce, B. Steinmann (Eds.), Connective Tissue and its Heritable Disorders, Chap. 10, Wiley-Liss, New York, 1993, pp. 317-350.
146. B. Steinmann, P.M. Royce, A. Superti-Furga, The Ehlers-Danlos syndrome, in: P.M. Royce, B. Steinmann (Eds.), Connective Tissue and its Heritable Disorders, Chap. 11, Wiley-Liss, New York, 1993, pp. 351-407.
147. J. Bollerslev, Osteopetrosis: a genetic and epidemiological study, Clin. Genet. 31 (1987) 86-90.
148. J. Bollerslev, Autosomal dominant osteopetrosis: bone metabolism and epidemiological clinical and hormonal aspects, Endocrinol. Rev. 4 (1995) 365-373.
149. M.P. Whyte, Osteopetrosis and the heritable forms of rickets, in: P.M. Royce, B. Steinmann (Eds.), Connective Tissue and its Heritable Disorders, Chap. 20, Wiley-Liss, New York, 1993, pp. 563-589.
150. W. Van Hul, J. Bollerslev, J. Gram et al., Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p21, Am. J. Hum. Genet. 61 (1997) 363-369.
151. M.J. Dixon, Treacher Collins syndrome, Hum. Mol. Genet. 5 (1996) 1391-1396, Review.
152. M.M. Cohen Jr., S. Kreiborg, E.J. Lammer et al., Birth prevalence study of the Apert syndrome, Am. J. Med. Genet. 42 (1992) 655-659.
153. R.M. Winter, Analysing human developmental abnormalities, BioEssays 18 (1996) 965-971.
154. A.O.M. Wilkie, Craniosynostosis: genes and mechanisms, Hum. Mol. Genet. 6 (1997) 1647-1656, Review.
155. M.M. Cohen, Perspectives on holoprosencephaly: I. Epidemiology, genetics and syndromology, Teratology 40 (1989) 211-235.
156. A.E. Rintala, R. Rinta, Lower lip sinuses: I. Epidemiology, microforms and transverse sulci, Br. J. Plast. Surg. 34 (1981) 26-30.
157. A.B. Burdick, D. Bixler, C.L. Puckett, Genetic analysis in families with Van der Woude syndrome, J. Craniofac. Genet. Dev. Biol. 5 (1985) 181-208.
158. O.Z. Dalgaard, Bilateral polycystic disease of the kidneys: a follow-up of 284 patients and their families, Acta Med. Scand. 328 (1957) 1-251.
159. E.R. Maher, I. Iselius, J.R.W. Yates et al., Von Hippel Lindau disease: a genetic study, J. Med. Genet. 28 (1991) 441-447.
160. R.W. Burt, W.S. Samowitz, The adenomatous polyp and the hereditary polyposis syndromes, Gastroenterol. Clin. N. Am. 17 (1988) 657-678.
161. M.S. Brown, J.L. Goldstein, Familial hypercholesterolemia: genetic, biochemical and pathophysiological considerations, Adv. Intern. Med. 20 (1975) 273-296.
162. S.E. Humphries, P.J. Talmud, Hyperlipidemia associated with genetic variation in the apolipoprotein B gene, Curr. Opin. Lipidol. 6 (1995) 215-222.
163. U. Abildgaard, Antithrombin and Related Inhibitors of Coagulation: Recent Advances in Blood Coagulation, Churchill Livingston, Edinburgh, 1981.
164. R.D. Rosenburg, Actions and interactions of antithrombin and heparin, New Engl. J. Med. 292 (1975) 146-151.
165. D.J. Perry, R.W. Carrell, Molecular genetics of human antithrombin deficiency, Human Mutation 7 (1996) 7-22.
166. H. Watkins, J.G. Seidman, C.G. Seidman, Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy, Hum. Mol. Genet. 4 (1994) 1721-1727, Review.
167. M.L. Budarf, B.S. Emanuel, Progress in the autosomal segmental aneusomy syndromes (SASs): single or multilocus disorders?, Hum. Mol. Genet. 6 (1997) 1657-1665, Review.
168. C.C. Carlson, H. Sirotkin, R. Pandita et al., Molecular definition of 22q11 deletions in 151 velocardiofacial syndrome patients, Am. J. Hum. Genet. 61 (1997) 620-629.
169. H. Plauchu, J.P. de Chadarevian, A. Bideau, J.H. Robert, Age-related profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population, Am. J. Med. Genet. 32 (1989) 291-297.
170. D.A. Marchuk, A.E. Guttmacher, J.A. Penner, P. Ganguly, Report on the workshop on hereditary hemorrhagic telangiectasia, Am. J. Med. Genet. 76 (1998) 269-273.
171. C. Petit, Genes responsible for human hereditary deafness: symphony of a thousand, Nat. Genet. 14 (1996) 385-391.
172. G. van Camp, P.J. Willems, R.J.H. Smith, Non-syndromic hearing loss: unparalleled heterogeneity, Am. J. Hum. Genet. 60 (1997) 758-764.
173. J.A. Boughman, P.M. Coneally, W.E. Nance, Population genetics of retinitis pigmentosa, Am. J. Hum. Genet. 32 (1980) 223-235.
174. T.P. Dryja, T. Li, Molecular genetics of retinitis pigmentosa, Hum. Mol. Genet. 4 (1995) 1739-1743, Review.
175. S.Y. Xu, M. Schwartz, T. Rosenburg, A. Gal, A ninth locus (RP18) for autosomal dominant retinitis pigmentosa maps in the pericentromeric region of chromosome 9, Hum. Mol. Genet. 5 (1996) 1193-1197.
176. F. Vogel, The genetics of retinoblastoma, Hum. Genet. 52 (1979) 1-54.
177. J.L. Young, J.L.G. Ries, E. Silverberg et al., Cancer incidence, survival and mortality for children less than 15 years of age, Cancer 58 (1986) 598-602.
178. G.M. Brodeur, Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma, in: B.A. Ponder et al. (Eds.), Cancer Surveys 25: Genetics and Cancer: A Second Look, CSHL Press, CSH, 1995, pp. 67-99.
179. L.B. Nelson, G.L. Spaeth, T. Nowinski et al., Aniridia: a review, Surv. Ophthalmol. 28 (1984) 621-642.
180. I.M. Hanson, A. Seawright, K. Hardman et al, PAX6 mutations in aniridia, Hum. Mol. Genet. 2 (1993) 915-920.
181. J. Waidestrom, Studies on the incidence and heredity of of acute porphyria in Sweden, Acta Genet. Stat. Med. 6 (1956) 122-131.
182. K.H. Astrin, R.J. Desnick, Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymeth-ylbilane synthase gene, Human Mutation 4 (1994) 243-252.
183. G.R. Fraser, The Causes of Profound Deafness in Childhood, Johns Hopkins Univ. Press, Baltimore, MD, 1976.
184. A.P. Read, V.E. Newton, Waardenburg syndrome, J. Med. Genet. 34 (1997) 656-665.
185. P. Puri, Hirschsprung's disease: clinical and experimental observations, World J. Surg. 17 (1993) 374-384.
186. T. Iwashita, H. Murakami, N. Asai, M. Takahashi, Mechanisms of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain, Hum. Mol. Genet. 5 (1996) 1577-1580.
187. M.L. Steer, I. Waxman, S. Freedman, Chronic pancreatitis, New Engl. J. Med. 332 (1995) 1482-1492.
188. D.C. Whitcomb, M.C. Gorry, R.A. Preston et al., Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene, Nat. Genet. 14 (1996) 141-145.
189. M.J. Dasouki, J. Cogan, M.L. Summar et al., Heterogeneity in hereditary pancreatitis, Am. J. Med. Genet. 77 (1998) 47-53.
190. P.M. Hopkins, F.R. Ellis, Inherited diseases affecting anaesthesia, in: T.E. Hely, P.J. Cohen (Eds.), A Practice of Anaesthesia, Edward Arnold, London, 1995, pp. 938-952.
191. R.L. Robinson, N. Monnier, W. Wolz, A genome-wide search for susceptibility loci in three European malignant hyperthermia pedigrees, Hum. Mol. Genet. 6 (1997) 953-961.
192. D.G.R. Evans, E.J. Ladusans, S. Rimmer et al., Complications of the nevoid basal cell carcinoma syndrome: results of a population-based study, J. Med. Genet. 30 (1993) 460-464.
193. R.J. Gorlin, Nevoid basal cell carcinoma syndrome, Dermatol. Clin. 13 (1995) 113-125.
194. H. Hahn, C. Wicking, P.G. Zaphiropoulos et al, Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome, Cell 85 (1996) 841-851.
195. D. Malkin, p53 and the Li-Fraumeni syndrome, Biochim. Biophys. Acta 1198 (1994) 197-213.
196. L.C. Tsui, The spectrum of cystic fibrosis mutations, Trends Genet. 8 (1992) 392-398.
197. M. Schwartz, N. Sorenson, N.J. Brandt et al, High incidence of cystic fibrosis on the Faroe Islands: a molecular and genealogical study, Hum. Genet. 95 (1995) 703-706.
198. B.E. Cohen, E. Budonyi, A. Steinberg, Phenylketonuria in Jews, Lancet i (1961) 344-345.
199. H. Bickel, C. Bachman, R. Beckers, Neonatal mass-screening for metabolic disorders, Eur. J. Pediatr. 137 (1981) 133-139.
200. K.J. Hoffman, G. Steel, H.H. Kazazian, D. Valle, Phenylketonuria in US blacks: molecular analysis of the phenylhydroxylase gene, Am. J. Hum. Genet. 48 (1991) 791-798.
201. S. Segal, S. Their, Cystinuria, in: C.R. Scriver et al. (Eds.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, pp. 2479-2496.
202. E. Andermann, C.R. Scriver, L.S. Wolf et al., Genetic variants of Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians and a Tay-Sachs screening program in the French Canadian population, Prog. Clin. Biol. Res. 18 (1977) 161-188.
203. B. Weber, X-H. Guo, J.E. Wraith et al., Novel mutations in Sanfillipo A syndrome implications for enzyme function, Hum. Mol. Genet. 6 (1997) 1573-1579.
204. R.B. Lowry, D.A. Applegarth, J.R. Toone et al., An update of the frequency of mucopolysaccharide syndromes in British Columbia, Hum. Genet. 85 (1990) 389-390.
205. K. Gustavson, B. Hagberg, The incidence and genetics of metachromatic leukodystrophy in Northern Sweden, Acta Pediatr. Scand. 60 (1971) 585-590.
206. V. Gieselmann, J. Zlotogora, A. Harris et al., Genetics of metachomatic leukodystrophy, Human Mutation 4 (1994) 233-242.
207. S.H. Mudd, H.L. Levy, F. Skovby, Disorders of transsufuration, in: C.L. Scriver et al. (Eds.), The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill, New York, 1989, pp. 693-734.
208. I. Scheinberg, I. Sternlieb, Wilson disease, in: H. Lloyd, J. Smith (Eds.), Major Problems in Internal Medicine, Vol 23, Saunders, Philadelphia, PA, 1984.
209. A. Figus, A. Angius, G. Loudianos et al, Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations, Am. J. Hum. Genet. 57 (1995) 1318-1324.
210. J.T. Coulombe, V.E. Shih, H.L. Levy, Massachussetts metabolic screening program: I. Methylmalonic aciduria, Pediatrics 67 (1981) 26-31.
211. A. Ledley, D.S. Rosenblatt, Mutations in mut methylmalonic aciduria: clinical and enzymatic correlations, Human Mutation 9 (1997) 1-6.
212. D.A. Wenger, M.A. Rafi, P. Luzi, Molecular genetics of Krabbe disease: globoid cell leukodystrophy: diagnostic and clinical implications, Human Mutation 10 (1997) 268-279.
213. D.R. Tolan, Molecular basis of hereditary fructose intolerance: mutations and polymorphisms in the human aldolase gene, Human Mutation 6 (1995) 210-218.
214. C.E. McLaren, V.R. Gordeuk, A.C. Looker, Prevalence of heterozygotes for hemochromatosis in the white population of the United States, Blood 86 (1995) 2021-2027.
215. A.T. Merryweather-Clarke, J.J. Pointon, J.D. Shearman, K.J.H. Robson, Global prevalence of putative hemochromatosis, J. Med. Genet. 34 (1997) 275-278.
216. M. Carella, L. D'Ambrosio, A. Totaro et al., Mutation analysis of the HLA-H in Italian hemochromatosis patients, Am. J. Hum. Genet. 60 (1997) 828-832.
217. G.J. Bruining, Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus, Curr. Opin. Pediatr. 2 (1990) 758-765.
218. P.M. Mathew, J.M. Young, Y.K. Abu-Osba et al, Persistent neonatal hyperinsulinism, Clin. Pediatr. 27 (1988) .
219. P.M. Mathew, N. Wohlik, E. Huang et al., Inactivation of the first nucleotide binding fold of the sulfonylurea receptor and familial persistent hyperinsulinemic hypoglycemia of infancy, Am. J. Hum. Genet. 59 (1996) 510-518.
220. J. Pearn, Classification of spinal muscular atrophies, Lancet i (1980) 919-922.
221. G.P. Romeo, P. Menozzi, A. Ferlini et al., Incidence of Friedreich's ataxia in Italy estimated from consanguineous marriages, Am. J. Hum. Genet. 35 (1983) 523-529.
222. J.M. Polo, J. Calleja, O. Combarros, J. Berciano, Hereditary ataxias and paraplegias in Cantabria, Spain: an epidemiological and clinical study, Brain 114 (1991) 855-866.
223. A. Filla, G. De Michele, F. Cavalcanti et al., The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich's ataxia, Am. J. Hum. Genet. 59 (1996) 554-560.
224. J.J. Carvajal, M. Pook, K. Doudney et al., Friedreich's ataxia: a defect in signal transduction?, Hum. Mol. Genet. 4 (1995) 1411-1419.
225. J.M. Lopez-Arlandis, J.J. Vilchez, F. Palau, T. Sevilla, Friedreich's ataxia: an epidemiological study in Valencia, Spain based on consanguinity analysis, Neuroepidemiology 14 (1995) 14-19.
226. E.S. Moreira, M. Vainzof, S.K. Marie, The seventh form of autosomal recessive limb girdle muscular dystrophy is mapped to 17q11-12, Am. J. Hum. Genet. 61 (1997) 151-159.
227. P.W. Speiser, B. Dupont, P. Rubinstein et al., High frequency of non-classical steroid 21-hydroxylase deficiency, Am. J. Hum. Genet. 37 (1985) 650-667.
228. A. Thilen, A. Larson, Congenital adrenal hyperplasia in Sweden, 1969-1986: prevalence, symptoms and age at diagnosis, Acta Pediatr. Scand. 79 (1990) 168-175.
229. A.G. Motulsky, Frequency of sickling disorders in US blacks, New Engl. J. Med. 288 (1973) 31-33.
230. T.B. Friedman, Y. Liang, J.L. Weber et al., A gene for congenital recessive deafness DFNB3 maps to the pericentromeric region of chromosome 17, Nat. Genet. 9 (1995) 86-91.
231. I. Stoilov, A.N. Akarsu, I. Alozie et al., Sequence analysis and homology modeling suggests that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1, Am. J. Hum. Genet. 62 (1998) 573-584.
232. G. Nigro, L.I. Comi, F.M. Limongelli et al., Prospective study of X-linked progressive muscular dystrophy in Campania, Muscle Nerve 6 (1983) 253-262.
233. W.R. Williams, M.W. Thompson, N.E. Morton, Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy, Am. J. Med. Genet. 14 (1983) 315-333.
234. K.M.D. Bushby, N.J. Cleghom, A. Curtis et al., Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy, Hum. Genet. 88 (1991) 195-199.
235. A.J. Van Essen, H.F.M. Busch, G.J. Te Meerman, L.P. Ten Kate, Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands, Hum. Genet. 88 (1992) 258-266.
236. A.E.H. Emery, Duchenne Muscular Dystrophy, 3rd edn., Oxford Univ. Press, Oxford, 1993.
237. L.J. Shapiro, R. Weiss, D. Webster, J.T. France, X-linked ichthyosis due to steroid sulphatase deficiency, Lancet i (1978) 70-72.
238. J. Kere, A.K. Srivastava, O. Montonen et al., X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein, Nat. Genet. 13 (1996) 409-416.
239. S.E. Antonarakis, The molecular genetics of hemophilia A and B in man, Adv. Hum. Genet. 17 (1988) 27-59.
240. P.A. McKee, Hemostasis and disorders of blood coagulation, in: J.B. Stanbury et al. (Eds.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1983, pp. 1531-1560.
241. C.J. Witkop, Abnormalities of pigmentation, in: A.E.H. Emery, D.L. Rimoin (Eds.), Principles and Practice of Medical Genetics, Chap. 52, Vol. 1, Livingstone, Edinburgh, 1990, pp. 797-833.
242. J.A.J.M. Van den Hurk, M. Schwartz, H. Van Bokhoven et al., Molecular basis of choroideremia (CHM): mutations involving the Rab Escrot Protein-1 (REP-1) gene, Human Mutation 9 (1997) 110-117.
243. C.M. Eng, R.J. Desnick, Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha galactosidase A gene, Human Mutation 3 (1994) 103-111.
244. J.M. Puck, Molecular basis for three X-linked immune disorders, Hum. Mol. Genet. 3 (1994) 1457-1461, Review.
245. R.N. Haire, Y. Ohta, J. Strong et al., Unusual pattern of exon skipping in Bruton tyrosine kinase associated with mutations involving the intron 17 3′ splice site, Am. J. Hum. Genet. 60 (1997) 798-807.
246. F. Francis, T.M. Strom, S. Hennig et al., Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets, Genome Res. 7 (1997) 573-585.
247. W. Zeman, Studies in the neuronal ceroid lipofuscinosis, J. Neuropathol. Exp. Neurol. 33 (1974) 1-12.
248. L. Bezman, H.W. Moser, Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes, Am. J. Med. Genet. 76 (1998) 414-419.
249. E.P.E. Kirk, J.M.F. Fletcher, P Sharp et al., X-linked adrenoleukodystrophy: the Australasian experience, Am. J. Med. Genet. 76 (1998) 420-423.
250. A.G. Motulsky, Jewish diseases and origins: news and views, Nat. Genet. 9 (1995) 99-101.
251. B. Roa, A. Boyd, K. Volcik et al., Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2, Nat. Genet. 14 (1996) 185-187.
252. P. Tonin, B. Weber, K. Offit et al., Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi breast cancer families, Nat. Med. 2 (1996) 1179-1183.
253. D. Abeliovich, L. Kaduri, I. Lever et al., The founder mutation 185delAG and 5382insC in BRCA1 and 617delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi women, Am. J. Hum. Genet. 60 (1997) 505-514.
254. M. Horowitz, A. Zimran, Mutations causing Gaucher disease, Human Mutation 3 (1994) 1-11.
255. R. Kaul, G.P. Gao, M. Aloya et al., Canavan disease: mutations among Jewish and non-Jewish patients, Am. J. Hum. Genet. 55 (1994) 34-41.
256. O. Levran, R.J. Desnick, E.H. Schuchman, Type A Niemann-Pick disease: a frameshift mutation in the acid sphingomyelinase gene (fs P330) occurs in Ashkenazi Jewish patients, Human Mutation 2 (1993) 317-319.
257. A.G. Motulsky, Possible selective effects of urbanization in Ashkenazi Jews, in: R.M. Goodman, A.G. Motulsky (Eds.), Genetic Diseases among Ashkenazi Jews, Raven Press, New York, 1979, pp. 301-312.
258. J. German, Bloom's syndrome: incidence, age of onset and types of leukemia in the Bloom syndrome registry, in: C.S. Bartsocas et al. (Eds.), Genetics of Hematological Disorders, Hemisphere Publishers, Washington, DC, 1992, pp. 241-258.
259. N.A. Ellis, J. German, Molecular genetics of Bloom's syndrome, Hum. Mol. Genet. 5 (1996) 1457-1463, Review.
260. C. Maayan, E. Kaplan, S. Shachar et al., Incidence of familial dysautonomia in Israel, 1971-1981, Clin. Genet. 32 (1997) 106-108.
261. A. Blumenfeld, S.A. Slaugenhaupt, F.B. Axelrod et al., Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis, Nat. Genet. 4 (1993) 160-164.
262. R. Asakai, D.W. Chung, E. Davie et al., Factor IX deficiency in Ashkenazi Jews in Israel, New Engl. J. Med. 325 (1991) 153-158.
263. A.B. Lane, T. Jenkins, Human L-xylulose reductase variation: family and population studies, Ann. Hum. Genet. 49 (1985) 227-235.
264. J. Zlotogora, Hereditary disorders among Iranian Jews, Am. J. Med. Genet. 58 (1995) 32-37.
265. H.H. Hobbs, M.S. Brown, D.W. Russell et al., Deletion in the gene for the low density lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia, New Engl. J. Med. 317 (1987) 734-737.
266. E. Leitersdorf, E.J. Tobin, J. Davignon, H.H. Hobbs, Common low density lipoprotein receptor mutations in the French Canadians, J. Clin. Invest. 85 (1990) 1014-1023.
267. M. De Braekeleer, Hereditary disorders in Saguenay-Lac-St. Jean (Quebec, Canada), Hum. Hered. 41 (1991) 141-146.
268. H.C. Seftel, S.G. Baker, M.P. Sandler et al., A host of hypercholesterolemic homozygotes in South Africa, Br. Med. J. 281 (1980) 633-636.
269. E. Leitersdorf, D.R. van der Westhuyzen, G.A. Coetzee, H.H. Hobbs, Two common low density lipoprotein gene mutations cause familial hypercholsterolemia in Afrikaners, J. Clin. Invest. 84 (1989) 954-961.
270. G. Dean, The Porphyrias: A Story of Inheritance and Environment, 2nd edn., J.B. Lippincot, Philadelphia, 1972.
271. P.N. Meissner, T.A. Dailey, R.J. Hift et al., A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria, Nat. Genet. 13 (1996) 95-97.
272. L. Warnick, M.J. Kotze, I.M. Groenewald et al., Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria, Hum. Mo. Genet. 5 (1996) 981-984.
273. S.A. Gayther, P. Harrington, P. Russell et al., Frequently occurring germline mutations of the BRCA1 gene in ovarian cancer families from Russia, Am. J. Hum. Genet. 60 (1997) 1239-1242.
274. T. Peelen, M. van Vliet, A. Petrij-Bosch et al., High frequencies of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families, Am. J. Hum. Genet. 60 (1997) 1041-1049.
275. V.A. McKusick, Non-homogeneous distribution of recessive diseases, in: R.M. Goodman, A.G. Motulsky (Eds.), Genetic Diseases among Ashkenazi Jews, Raven Press, New York, 1979, pp. 271-284.
276. W.L. Greer, D.C. Riddell, D.M. Byers et al., Linkage of Niemann-Pick disease type D to the same region of human chromosome 18 as Niemann-Pick disease type C, Am. J. Hum. Genet. 61 (1997) 139-142.
277. M. Grompe, M. St. Louis, S.I. Demers et al., A single mutation of the fumaryloacetoacetate hydrolase gene in French Canadians of hereditary tyrosinemia type I, New Engl. J. Med. 331 (1994) 353-357.
278. P. Gadbois, J. Moreau, C. Laberge, La maladie de Morquio dans la province de Quebec, Un. Med. Can. 102 (1973) 602-607.
279. R. Myerowitz, N.D. Hogikyan, A deletion involving Alu sequences in the betahexosaminidase alpha-chain gene of French Canadians with Tay-Sachs disease, J. Biol. Chem. 262 (1987) 15396-15399.
280. P. Hechtman, F. Kaplan, J. Bayleran et al., More than one mutant allele causes infantile Tay-Sachs disease in French Canadians, Hum. Genet. 47 (1990) 815-822.
281. M. Daniels, T. Shohat, A. Brenner-Ulman, M. Shohat, Familial mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel, Am. J. Med. Genet. 55 (1995) 311-314.
282. G.B. Rogers, M. Shohat, G.M. Peterson et al., Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency, Am. J. Med. Genet. 34 (1995) 168-172.
283. French FMF Consortium, A candidate gene for familial mediterranean fever, Nat. Genet. 17 (1997) 25-31.
284. J. Zlotogora, Autosomal recessive diseases among Palestinians, J. Med. Genet. 34 (1997) 765-766.
285. R.P. Ketterling, C.D.K. Bottema, D.D. Koeberl et al., T296-to-M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays and rapid carrier detection, Hum. Genet. 52 (1991) 333-337.
286. R.A. Norum, R.G. Lafreieniere, L.W. O'Neill et al., Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A, Genomics 8 (1990) 313-317.